News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Global equity indices traded flat near prior close over the past hour.
  • US Treasury yields were largely unchanged, leaving bond volatility subdued.
  • No major economic data or central bank comments were released in the past hour.
  • No new geopolitical developments were reported that would affect commodity or risk markets.
  • Oil and gold prices were little changed during the hour.
  • Major legislative or corporate headlines were absent, leaving market catalysts scarce.

Latest Articles

Boris Nadezhdin Says He Has Left Russia, Posts Video from Paris

Boris Nadezhdin Says He Has Left Russia, Posts Video from Paris

Boris Nadezhdin, a 63-year-old former liberal lawmaker and outspoken critic of Russia's war in Ukraine, said he has left Russia and is currently abroad. In a short video posted on Telegram from the Eiffel Tower in Paris, he said he was "alive and free" and would outline his next steps later. His exit follows his inclusion on Russia's "foreign agent…

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Helus Pharma announces the appointment of Michael Halstead as CEO to lead the company through critical late-stage clinical development and commercialization phases. Halstead brings 25 years of experience from Intra-Cellular Therapies, including a successful track record in drug development, launch, and commercialization. The company is advancing HL…

Genprex Shares Slide After Early Rally on Roche Diagnostics Collaboration

Genprex Shares Slide After Early Rally on Roche Diagnostics Collaboration

Genprex stock tumbled 12.4% in pre-market trading after an initial uptick following a newly announced collaboration with Roche Diagnostics to validate TROP2 and PTEN as biomarkers for non-small cell lung cancer trials. The deal briefly lifted the micro-cap's shares by about 3% before selling pressure erased gains. Broader U.S. equity indices were p…

Curium Announces Definitive Agreement to Merge with Lantheus

Curium Announces Definitive Agreement to Merge with Lantheus

Curium US Holdings is acquiring Lantheus Holdings in an $8 billion deal that will consolidate complementary radiopharmaceutical portfolios and global manufacturing and commercial platforms. The transaction offers Lantheus shareholders $102.50 per share in cash at closing plus up to $12.00 per share in contingent value rights tied to commercial mile…

Navigator Gas Announces Signing of $121.8 Million Financing for Two Newbuild Ammonia Carriers in Navigator Amon Joint Venture

Navigator Gas Announces Signing of $121.8 Million Financing for Two Newbuild Ammonia Carriers in Navigator Amon Joint Venture

Navigator Holdings Ltd. announced the signing of a $121.8 million senior secured loan facility to finance two newbuild ammonia-fueled liquefied ammonia carriers currently under construction in China. The financing supports the company's ammonia growth strategy, enabling delivery of the vessels in 2028 with a six-year post-delivery tenor and competi…

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

ARS Pharmaceuticals, a biopharmaceutical company focused on treatments for allergic reactions and anaphylaxis, announced a conference call and webcast on August 13, 2026, to outline updated strategic priorities and report their Q2 2026 financial results. The company is commercially offering neffy®, an epinephrine nasal spray approved for emergency …

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma Ltd. appoints Dr. Faisal Mehmud, Chief Medical Officer and Co-Chairman of Antev Limited, as CEO of its UK subsidiary effective August 30, 2026. This leadership move aims to unify scientific, clinical, regulatory, and operational efforts as the company advances development of Teverelix®, targeting advanced prostate cancer, urinary ret…

Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform

Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform

Hydrofarm Holdings Group, Inc. has completed the sale of its subsidiary Aurora Peat Products to Raven Holdings LLC for $16 million, applying proceeds to reduce debt and simplify operations. The company will maintain a supply agreement with Aurora Peat and plans to focus on scaling its logistics services platform through a new initiative named Proje…

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics announced the publication of a four-year longitudinal real-world study assessing its FDA-approved drug MIPLYFFA® (arimoclomol) in treating Niemann-Pick disease type C (NPC). The study, covering 109 U.S. patients including adults, showed stable disease severity scores and confirmed the drug's known safety profile. This data streng…

SOLOWIN HOLDINGS’ (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin

SOLOWIN HOLDINGS’ (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin

Solowin Holdings' subsidiary AX Coin Bahrain has achieved a significant milestone by obtaining formal Sharia certification for its AXBHD stablecoin. This certification, conducted by the Shariyah Review Bureau licensed by the Central Bank of Bahrain, marks AXBHD as the first central bank-regulated stablecoin to receive such recognition. The certific…

South African opposition party takes legal fight over expropriation law to court

South African opposition party takes legal fight over expropriation law to court

South Africa's Democratic Alliance has filed a court challenge to the Expropriation Act, a law allowing the state to seize land in the public interest and cited by U.S. President Donald Trump when he cut off aid last year. The move has increased tensions within the governing coalition with the African National Congress as the country approaches mun…

Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors

Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors

Autolus Therapeutics reported preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million with a gross margin improvement to around 35%. The company raised 2026 sales guidance to $140–$150 million, up from $120–$135 million. Autolus secured a $250 million five-year credit facility with Perceptive Advisors, including $75 million fu…

June Camera Shipments Slide 14.6% as Mirrorless Suffer the Biggest Drop

June Camera Shipments Slide 14.6% as Mirrorless Suffer the Biggest Drop

Digital camera shipments fell 14.6% year-over-year in June 2026, according to Camera Imaging Products Association figures cited by Morgan Stanley. Shipment value declined 3.0% over the same period. The downturn affected both built-in lens and interchangeable-lens categories, with mirrorless cameras experiencing the steepest fall. Regional results w…

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month

OwlTing Group reported a 107.6% increase in payment volume and a 109.5% rise in transaction count for its digital currency-based cross-border payment platform, OwlPay Harbor, in July 2026 compared to June. The company continues to expand enterprise clients and transaction activity across multiple global markets, leveraging its regulatory licenses a…

DT Midstream: Premium Valuation Justified by A Brownfield Growth Engine

DT Midstream: Premium Valuation Justified by A Brownfield Growth Engine

DT Midstream (DTM) trades at a premium for a midstream name, but the multiple is increasingly supported by a $1.2B brownfield acquisition, improving pipeline mix, and $480M in free cash flow. We lay out a mid-term (45 trading days) long trade with entry at $137.00, target $152.00 and stop $126.00, and explain the catalysts and risks that make the s…